← All trials
NCT01329757
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2011
- Primary completion
- Nov 1, 2015
- Completion date
- Nov 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 76
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Hospital Nacional de ParaplejicosLead sponsor
- Hospital Nacional de ParaplejicosOverall official - principal investigator
- Government of ArgentinaCollaborator
- Hospital Nacional de ParaplejicosReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.